MSI-H/dMMR advanced cancer (mono, 2L+)

Advanced BTC (combo with chemo vs. chemo, 1L)

NSCLC (Adjuvant/Neo-adjuvant therapy, 1L)

G/GEJ advanced cancer (combo with chemo, 1L)

TMB-H advanced cancer (mono, 2L+)

EC (mono and combo with lenvatinib, 2L+)

HCC, CRC, NSCLC (combo with BD0801)

Microsatellite stable CRC (combo with cetuximab+/- Fruquintinib, standard treatment failure)

dMMR advanced solid tumors (mono, 2L+)

Healthy Volunteers

Cancer pain / osteoarthritis

Advanced malignant solid tumors

Multiple indications

Multiple indications